Literature DB >> 25020113

Extremely large nuchal translucency measurement predicts adverse pregnancy outcome.

S Pitkanen1, P Laitinen, A Yla-Outinen, M Heikkila, T Honkasalo, M Ryynanen, J Marttala.   

Abstract

A prospective study was conducted to determine the outcome of pregnancies with 1st trimester nuchal translucency measurement of ≥ 6.5 mm. The risk of fetal abnormalities increases with enlarging nuchal translucency, being around 45% with a measurement of ≥ 6.5 mm. A total of 27,144 women with singleton pregnancies participated in the combined Down syndrome screening within the public healthcare system in Northern Finland. The study period was 1 May 2002 to 31 May 2009. The nuchal translucency measurement was ≥ 6.5 mm in 16 cases (0.06%). Pregnancy outcome was normal in one case (6.3%). The risk of abnormality was higher in our study than reported in the literature. According to our study, immediate diagnostic tests should be offered after an nuchal translucency measurement of ≥ 6.5 mm. We should also consider analysis of fetal micro-deletions associated with certain syndromes.

Entities:  

Keywords:  1st trimester; Down syndrome; nuchal translucency; singleton pregnancy; ultrasound screening

Mesh:

Year:  2014        PMID: 25020113     DOI: 10.3109/01443615.2014.935713

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Fetal Nasal Bone Length as a Novel Marker for Prediction of Adverse Perinatal Outcomes in the First-Trimester of Pregnancy.

Authors:  Mehmet Tunç Canda; Namık Demir; Orçun Sezer
Journal:  Balkan Med J       Date:  2017-04-05       Impact factor: 2.021

2.  Neurodevelopmental outcome at 2 years of corrected age in fetuses with increased nuchal translucency thickness and normal karyotype compared with matched controls.

Authors:  R Buffin; A Fichez; E Decullier; A Roux; S Bin; D Combourieu; B Pastor-Diez; C Huissoud; J-C Picaud
Journal:  Ultrasound Obstet Gynecol       Date:  2021-04-07       Impact factor: 7.299

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.